Overview

Greenphire specializes in financial lifecycle management solutions specifically for clinical trials. The company provides a suite of software that automates financial processes such as budgeting, payment processing, and financial reporting for clients in the pharmaceutical and clinical research sectors. By streamlining these operations, Greenphire helps clients reduce administrative tasks and improve financial visibility, allowing clinical trial teams to concentrate more on patient care rather than financial management. Unlike many competitors, Greenphire focuses solely on the financial aspects of clinical trials, ensuring maximum transparency and control throughout the process. The company's goal is to enhance the efficiency and effectiveness of financial management in clinical trials, benefiting all parties involved.

💡 Want to apply to Greenphire?

You have ways to get a Greenphire referral from your network.

Get referrals →

Simplify's Take

What believers are saying

• Merger with Suvoda enhances capabilities in supporting complex clinical studies.
• Partnership with Citeline offers comprehensive clinical trial data solutions.
• Launch of Patient Experience Dataset transforms clinical trial planning and patient journey insights.

What critics are saying

• Integration challenges post-merger with Suvoda could disrupt operations.
• New executive appointments may lead to strategic shifts affecting operations.
• Acquisition of Clincierge poses integration risks and potential cultural clashes.

What makes Greenphire unique

• Greenphire automates financial processes for clinical trials, reducing administrative burdens.
• The company offers a subscription-based model, providing continuous revenue streams.
• Greenphire's solutions enhance financial transparency and predictability in clinical trials.

Help us improve and share your feedback! Did you find this helpful?

YesNo

Funding

Total Funding

$5.8M

Below

Industry Average

Funded Over

2 Rounds

$4,300,000

Series B

Oct 2012

Series B funding is typically for startups that have proven their business model and need more funding to expand rapidly—often by entering new markets or adding more products. Investors are usually venture capital firms that specialize in later-stage investments.

Series B Funding Comparison

Below Average

Industry standards

Ind Avg. $35M

$4M

$4.3M

$30M

$45M

$65M

$100M

View all funding stages